TGFB1 and neoplasm: In the adaptive immune response, TGF-β regulates the production of a variety of cytolytic genes including granzyme A, granzyme B, IFNγ, and FAS ligands, which impair the anti-tumor activity of CD8 + T cells, ultimately leading to pro-tumor TME [55,56].